HUMANPLASMAÄHNLICHES MEDIUM
European patent · EP3538151 · In force
Register entry
- Publication number
- EP3538151
- Application number
- EP17869135
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 13, 2017
- Published
- Sep 18, 2019
- Granted
- Jun 26, 2024
- Protection ends at the latest
- Nov 12, 2037
- Next annual fee due
- Nov 30, 2026
- IPC classes
- A61K 39/395 (2006.01)C07K 16/00 (2006.01)C07K 16/18 (2006.01)A61P 19/06 (2006.01)A61P 35/00 (2006.01)A61P 43/00 (2006.01)C07K 1/00 (2006.01)C12N 5/00 (2006.01)
- Priority
- US 201662421074 P 11.11.2016
- PCT application
- PCT/US2017/061377 13.11.2017
- PCT publication
- WO2018/089928 17.05.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- May 7, 2025
Change
Published in Swissreg on 07.05.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Jun 26, 2024
Granted
Published in Swissreg on 26.06.2024
Parties
Inventor
CANTOR, Jason
Cambridge, MA 02142, US
SABATINI, David, M.
Cambridge, MA 02138, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.